Digestive Disease Week® (DDW) 2026- 2–5 May 2026, Chicago, Illinois, USA & Onlin

<p>​​DDW 2026 brought together leading experts in gastroenterology, hepatology, endoscopy, and gastrointestinal surgery to showcase the latest scientific and clinical advancements.</p><p>The conference highlights largely reinforce current evidence supporting the role of GLP-1 receptor agonists and SGLT2 inhibitors in the management of MASLD/MASH, while also providing additional insights into UDCA outcomes and the long-term safety of proton pump inhibitors (PPIs).</p>